Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin for UEDVT in Cancer Patients with Central Venous Catheters
NCT00216866Phase 2Completed
- Start
- Sep 2002
- Primary completion
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dalteparin in upper extremity deep vein thrombosis (UEDVT). Started Sep 2002; status: completed.
02
Drugs
dalteparin
03
Conditions
upper extremity deep vein thrombosis (UEDVT)
Beyond the preview
Go deeper on NCT00216866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216866.